Satterfield increased his passive stake but remains below 10% and has certified passive intent. Monitor for any future conversion to 13D or further accumulation above 10%, which could signal a shift in strategy.
CRIS drugs
CRIS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 10 $0.6530entry
- T+1 · 6d ago −9.42%α −10.74% · $0.5915
- T+4 · todayOpen
- T+5 · in 4h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Thomas A. Satterfield Jr. filed an amended Schedule 13G disclosing beneficial ownership of 616,565 shares (8.8% of outstanding common stock) as of September 30, 2026, up from 484,840 shares in his prior filing. The increase reflects additional share and warrant holdings, but the filing remains a passive 13G, indicating no activist intent.
Key Financial Metrics
Key Facts
- Thomas A. Satterfield Jr. reported beneficial ownership of 616,565 shares (8.8% of outstanding common stock) as of September 30, 2026.
- The stake includes 326,500 shares of common stock and 290,065 warrants with a 9.99% beneficial ownership limitation.
- The prior SC 13G/A filed May 14, 2026 reported 484,840 shares; the current filing shows an increase of 131,725 shares.
- The filing is a passive 13G, certifying the securities were not acquired to change or influence control of the issuer.
- Shares outstanding used for calculation: 6,679,229 as of October 26, 2026 per the issuer's proxy statement.
Financial Impact
Stake increased by approximately 131,725 shares; current stake value at market cap of $6M implies roughly $528,000.
Risk Factors
- Passive 13G status could change to 13D if Satterfield engages with management or seeks board representation.
- Warrant overhang exists: 290,065 warrants with a 9.99% exercise limitation could add dilution if exercised.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001104659-26-125055 |
| Document: 0001104659-26-125055-index.html | 0001104659-26-125055 |
| Document: 0001104659-26-125055.txt | 0001104659-26-125055 |
Track record
18 reports on CRIS
7 of 9 bullish or bearish reports moved the stock their way by T+1. Best: +82.45% at T+60 after the May 22, 2026 report. 9 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $0.4200 Now $0.4400 +4.76% settles Nov 17
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $0.6000 Now $0.4400 −26.67% settles Nov 17
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $0.5010 Now $0.4400 −12.18% settles Nov 17
- Nov 13, 20263d ago S-3 Bearish 7/10 Entry $0.6000 Now $0.4400 +26.67% settles Nov 17
- Nov 13, 20263d ago 8-K Neutral 4/10 Entry $0.4450 Now $0.4400 −1.12% settles Nov 17
- Nov 12, 20264d ago Press Release Bearish 6/10 Entry $0.4450 to $0.4358 Now $0.4400 +1.12% ▲ +2.07% +0.16% vs SPY
- Nov 10, 20266d ago SC 13G/A Neutral 3/10 Viewing Entry $0.6530 to $0.5915 Now $0.4400 −32.62% ▼ −9.42% −10.74% vs SPY
- Nov 6, 202610d ago 8-K Bearish 7/10 Entry $0.6976 to $0.6530 Now $0.4400 +36.93% ▲ +6.39% +6.03% vs SPY
- Nov 2, 202614d ago DEF 14A Neutral 4/10 Entry $0.6610 to $0.7139 Now $0.4400 −33.43% ▲ +8.00% +7.70% vs SPY
- Oct 19, 202628d ago 8-K Bearish 6/10 Entry $0.3996 to $0.3920 Now $0.4400 −10.11% ▲ +1.90% +2.43% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers